IL2 and neoplasm: To evaluate the impact of IL-2 on the GVL activity more precisely, we tested the anti-tumor effect in less inflammatory transplant setting with reduced splenocytes (1×106) and increased tumor cells (1×105), because this experimental setting minimizes the impact of GVHD on survival and can focus primarily on the GVL activity (Figure 7A).